Market Tracker

12/22 8:57am ET

Immunomedics Inc (NASDAQ:IMMU)

4.48
Data as of Dec 19
 +0.03 / +0.67%
Today’s Change
3.04
Today|||52-Week Range
6.17
-2.61%
Year-to-Date

Today’s Trading

Previous close4.45
Today’s open4.44
Day’s range-- - --
Volume1,484,490
Average volume (3 months)769,709
Market cap$417.2M
Dividend yield--
Data as of 12/19/2014

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-19.05%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book10.60

Competitors

 Today’s
change
Today’s
% change
CLDNCelladon Corp+0.06+0.32%
ARDXArdelyx Inc-0.19-0.79%
LMNSLumenis Ltd+0.31+3.35%
IVCInvacare Corp+0.27+1.65%
Data as of 12/19/2014

Financials

Next reporting dateFebruary 3, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts